Ultralife Corporation (ULBI)
NASDAQ: ULBI · Real-Time Price · USD
5.19
+0.03 (0.58%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Ultralife Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.89 | 9.35 | 6.85 | 10.28 | 5.71 | 8.41 |
Cash & Short-Term Investments | 8.89 | 9.35 | 6.85 | 10.28 | 5.71 | 8.41 |
Cash Growth | 1.96% | 36.34% | -33.31% | 79.91% | -32.09% | -21.03% |
Accounts Receivable | 34.43 | 33.95 | 29.37 | 31.76 | 27.78 | 20.23 |
Inventory | 57.29 | 54.01 | 51.36 | 42.22 | 41.19 | 33.19 |
Other Current Assets | 9.5 | 8.5 | 9.57 | 5.95 | 4.3 | 4.69 |
Total Current Assets | 110.1 | 105.8 | 97.16 | 90.2 | 78.99 | 66.52 |
Net Property, Plant & Equipment | 40.12 | 40.4 | 40.49 | 21.12 | 21.72 | 23.21 |
Other Intangible Assets | 10.65 | 10.93 | 24.56 | 15.11 | 15.92 | 17.39 |
Goodwill | 45.33 | 45.38 | 45.01 | 37.57 | 37.43 | 38.07 |
Other Long-Term Assets | 14.43 | 14.41 | 13.24 | 14.28 | 14.38 | 14.35 |
Total Assets | 220.63 | 216.91 | 220.45 | 178.28 | 168.43 | 159.54 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 24.06 | 17.42 | 14.16 | 11.34 | 16.07 | 9.82 |
Accrued Expenses | 15.56 | 15.79 | 12.38 | 10.39 | 10.84 | 7.1 |
Current Portion of Long-Term Debt | 3.44 | 4.13 | 2.75 | 2 | 2 | 2 |
Total Current Liabilities | 43.05 | 37.33 | 29.29 | 23.73 | 28.91 | 18.92 |
Long-Term Debt | 44.19 | 45.53 | 51.5 | 23.62 | 19.31 | 18.86 |
Other Long-Term Liabilities | 3.64 | 3.92 | 5.47 | 5.5 | 3.8 | 4.01 |
Total Long-Term Liabilities | 47.83 | 49.45 | 56.97 | 29.12 | 23.11 | 22.87 |
Total Liabilities | 90.89 | 86.78 | 86.26 | 52.85 | 52.03 | 41.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.11 | 2.11 | 2.11 | 2.08 | 2.06 | 2.05 |
Treasury Stock | -21.49 | -21.49 | -21.49 | -21.49 | -21.48 | -21.47 |
Additional Paid-in Capital | 192.86 | 192.86 | 191.83 | 189.16 | 187.41 | 186.52 |
Accumulated Other Comprehensive Income | -3.06 | -3.14 | -4.01 | -3.66 | -3.75 | -1.65 |
Retained Earnings | -40.79 | -40.34 | -34.44 | -40.75 | -47.95 | -47.83 |
Total Common Shareholders' Equity | 129.63 | 130 | 134 | 125.33 | 116.28 | 117.62 |
Minority Interest | 0.12 | 0.14 | 0.19 | 0.1 | 0.13 | 0.13 |
Shareholders' Equity | 129.75 | 130.13 | 134.19 | 125.43 | 116.4 | 117.74 |
Total Liabilities & Equity | 220.63 | 216.91 | 220.45 | 178.28 | 168.43 | 159.54 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 47.63 | 49.65 | 54.25 | 25.62 | 21.31 | 20.86 |
Net Cash (Debt) | -38.74 | -40.31 | -47.4 | -15.35 | -15.6 | -12.44 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.33 | -2.42 | -2.83 | -0.95 | -0.97 | -0.78 |
Book Value | 129.63 | 130 | 134 | 125.33 | 116.28 | 117.62 |
Book Value Per Share | 7.78 | 7.81 | 7.99 | 7.72 | 7.21 | 7.33 |
Tangible Book Value | 73.65 | 73.69 | 64.43 | 72.65 | 62.93 | 62.16 |
Tangible Book Value Per Share | 4.42 | 4.43 | 3.84 | 4.48 | 3.90 | 3.88 |